Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Surgeons Slow to Learn Keyhole Surgery for Prostate Cancer

By HospiMedica International staff writers
Posted on 16 Apr 2009
Surgeons who operate on patients with prostate cancer find it harder to learn the skills needed to do the surgery with a laparoscope compared with traditional techniques, claims a new study.

Researchers at Memorial Sloan Kettering Cancer Center (MSKCC, New York, NY, USA) calculated the learning curve for surgeons who did prostate surgery using a laparoscope, and found that these surgeons had to do around 750 operations before they achieved the same low level of disease recurrence as other surgeons achieved after 250 traditional operations. More...
The result is that patients are at increased risk of cancer recurrence if they are treated by surgeons who have anything less than the very highest levels of experience. The findings suggest that as inexperienced surgeons have lower rates of cure, prostate cancer patients should be advised to seek care from specialist cancer centers, where the surgeons specialize in the treatment of just one or two cancers.

The researchers also found that surgeons who already had experience of traditional prostate surgery had substantially worse results in terms of cancer recurrence when they first switched to doing surgery using a laparoscope than surgeons whose first experience of prostate surgery was using a laparoscope. In fact, the skills needed for laparoscopy were so hard to pick up for surgeons who already had previous experience of traditional prostate surgery that the authors suggested surgeons should not switch between open and laparoscopic procedures without a compelling reason. The study was published early online on April 1, 2009, in The Lancet Oncology.

"Laparoscopic radical prostatectomy appears to involve skills that do not translate well from open experience," concluded lead author Andrew Vickers, Ph.D., and colleagues of the department of epidemiology and biostatistics. "Clinical, educational and research initiatives are required in order to moderate the negative effects of the learning curve on clinical care."

Related Links:

Memorial Sloan Kettering Cancer Center




Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.